P. Karjalainen

发表

Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry.

G. Lip, W. Nammas, T. Kiviniemi, 2018, International journal of cardiology.

Bivalirudin use during percutaneous coronary intervention in patients on chronic warfarin therapy.

G. Lip, M. Niemelä, W. Nammas, 2014, Thrombosis research.

Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Results from the AFCAS registry.

G. Lip, M. Niemelä, S. Vikman, 2012, Circulation journal : official journal of the Japanese Circulation Society.

How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: to "bridge" or not to "bridge"?

G. Lip, A. Schlitt, A. Rubboli, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stent implantation in a real-world population: a comparison with paclitaxel-eluting stents: the PORI registry.

Antti Ylitalo, J. Airaksinen, W. Nammas, 2011, Journal of interventional cardiology.

Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE ACS randomized controlled trial: Bioactive versus everolimus-eluting stents in elderly patients.

M. Niemelä, W. Nammas, P. Karjalainen, 2017, European journal of internal medicine.

Impact of Calcified Target Lesions on the Outcome of Percutaneous Coronary Intervention for Acute Coronary Syndrome: Insights From the BASE ACS Trial

J. Airaksinen, W. Nammas, P. Karjalainen, 2017, Journal of interventional cardiology.

Impact of Preexisting Vascular Disease on the Outcome of Patients With Acute Coronary Syndrome: Insights From the Comparison of Bioactive Stent to the Everolimus-Eluting Stent in Acute Coronary Syndrome Trial

J. Airaksinen, W. Nammas, P. Karjalainen, 2017, Angiology.

Clinical outcome of titanium‐nitride‐oxide‐coated cobalt‐chromium stents in patients with de novo coronary lesions: 12‐month results of the OPTIMAX first‐in‐man study

W. Nammas, P. Karjalainen, J. Mikkelsson, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Long-term clinical outcome of titanium-nitride-oxide-coated stents versus everolimus-eluting stents in acute coronary syndrome: Final report of the BASE ACS trial.

J. Airaksinen, W. Nammas, P. Karjalainen, 2016, International journal of cardiology.

Long-term outcome of early percutaneous coronary intervention in diabetic patients with acute coronary syndrome: insights from the BASE ACS trial

J. Airaksinen, W. Nammas, P. Karjalainen, 2016, Annals of medicine.

4-Year outcome of bioactive stents versus everolimus-eluting stents in acute coronary syndrome

M. Niemelä, W. Nammas, P. Karjalainen, 2016, Scandinavian Cardiovascular Journal.

Pooled analysis of two randomized trials comparing titanium-nitride-oxide-coated stent versus drug-eluting stent in STEMI.

M. Niemelä, J. Airaksinen, W. Nammas, 2014, Revista espanola de cardiologia.

Mid-term clinical outcome of titanium-nitride-oxide-coated cobalt-chromium stents in patients with de novo coronary lesions: OPTIMAX first-in-man study.

W. Nammas, P. Karjalainen, A. Ylitalo, 2014, Revista espanola de cardiologia.

Stent-oriented versus patient-oriented outcome in patients undergoing early percutaneous coronary intervention for acute coronary syndrome: 2-year report from the BASE-ACS trial

J. Airaksinen, W. Nammas, P. Karjalainen, 2013, Annals of medicine.

Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a 12-months follow-up report from the TITAX AMI trial.

M. Niemelä, T. Mäkikallio, P. Karjalainen, 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction

M. Niemelä, T. Mäkikallio, P. Karjalainen, 2009, Annals of medicine.

Long-term clinical outcome with titanium-nitride-oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population.

T. Vahlberg, P. Karjalainen, A. Ylitalo, 2010, International journal of cardiology.

Safety of diagnostic coronary angiography during uninterrupted therapeutic warfarin treatment.

P. Karjalainen, P. Porela, A. Ylitalo, 2008, The American journal of cardiology.

Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry

J. Hartikainen, G. Lip, W. Nammas, 2017, Clinical cardiology.

Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry

G. Lip, J. Airaksinen, T. Kiviniemi, 2017, American heart journal.

Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: the AFCAS study.

P. Kirchhof, G. Lip, T. Kiviniemi, 2015, International journal of cardiology.

Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention.

G. Lip, M. Niemelä, S. Vikman, 2014, The American journal of cardiology.

Percutaneous revascularization of coronary chronic total occlusion: Toward a reappraisal of the available evidence.

W. Nammas, P. Karjalainen, 2017, Journal of cardiology.

Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry

G. Lip, T. Kiviniemi, A. Schlitt, 2017, Clinical Research in Cardiology.

Renal sympathetic denervation for treatment of patients with heart failure: summary of the available evidence

W. Nammas, P. Karjalainen, J. Koistinen, 2017, Annals of medicine.

Hydroxychloroquine reduces interleukin-6 levels after myocardial infarction: The randomized, double-blind, placebo-controlled OXI pilot trial.

J. Sinisalo, P. Kovanen, T. Nieminen, 2021, International journal of cardiology.

Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry

P. Kirchhof, G. Lip, J. Airaksinen, 2014, BMJ Open.

Transcatheter Leadless Pacemaker Implantation in a Patient with Recurrent Complications Following Transvenous Pacemaker Systems

P. Karjalainen, 2017 .

Transcatheter leadless pacemaker implantation in a patient with a transvenous dual-chamber pacemaker already in place.

W. Nammas, P. Karjalainen, T. Paana, 2016, Journal of electrocardiology.

Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment.

M. Niemelä, S. Vikman, T. Vahlberg, 2008, European heart journal.

Personalized ADP-receptor inhibition strategy and outcomes following primary PCI for STEMI (PASTOR study).

P. Karjalainen, J. Mikkelsson, T. Paana, 2016, International journal of cardiology.

Assessment of early treatment response by rapid cardiothoracic ultrasound in acute heart failure: Cardiac filling pressures, pulmonary congestion and mortality

P. Karjalainen, V. Harjola, J. Lassus, 2018, European heart journal. Acute cardiovascular care.

Rapid cardiothoracic ultrasound protocol for diagnosis of acute heart failure in the emergency department

P. Karjalainen, V. Harjola, J. Lassus, 2017, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology.

E. Mirrakhimov, Gani Bajraktari, T. Marandi, 2021, European heart journal.

Usefulness of outpatient bleeding risk index to predict bleeding complications in patients with long-term oral anticoagulation undergoing coronary stenting.

M. Niemelä, S. Vikman, P. Karjalainen, 2010, The American journal of cardiology.

Thrombocytopenia in patients with atrial fibrillation on oral anticoagulation undergoing percutaneous coronary intervention.

G. Lip, M. Niemelä, T. Kiviniemi, 2013, The American journal of cardiology.

Magnesium 2000 postmarket evaluation: Guideline adherence and intraprocedural performance of a sirolimus-eluting resorbable magnesium scaffold.

P. Karjalainen, A. Komócsi, J. Rumoroso, 2019, Cardiovascular revascularization medicine : including molecular interventions.

Response to letters regarding article, "Bacterial signatures in thrombus aspirates of patients with myocardial infarction".

T. Lehtimäki, J. Airaksinen, R. Laaksonen, 2013, Circulation.

Why don't we return to bare metal stents?

R. D. de Winter, O. Hess, L. Wallentin, 2008, EuroIntervention.

Comparison between the STENTYS self-apposing bare metal and paclitaxel-eluting coronary stents for the treatment of saphenous vein grafts (ADEPT trial)

C. Şimşek, P. Karjalainen, A. IJsselmuiden, 2017, Netherlands Heart Journal.

Are glycoprotein inhibitors safe during percutaneous coronary intervention in patients on chronic warfarin treatment?

M. Niemelä, S. Vikman, P. Karjalainen, 2009, Thrombosis and Haemostasis.

Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention

G. Lip, M. Niemelä, T. Kiviniemi, 2013 .

Pooled analysis of trials comparing titanium-nitride-oxide-coated stents with paclitaxel-eluting stents in patients undergoing coronary stenting.

O. Hess, M. Billinger, P. Karjalainen, 2010, The Journal of invasive cardiology.

Routine revascularization with percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation - the third Nordic Aortic Valve Intervention Trial - NOTION-3.

C. Terkelsen, K. Veien, T. Engstrøm, 2022, American heart journal.

Long-term safety of drug-eluting stents in patients on warfarin treatment

M. Niemelä, S. Vikman, P. Karjalainen, 2012, Annals of medicine.

University of Birmingham Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention

J. Airaksinen, W. Nammas, T. Kiviniemi, 2014 .

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

P1177Impact of incomplete revascularization in atrial fibrillation patients undergoing percutaneous coronary intervention: the afcas registry

G. Lip, T. Kiviniemi, A. Schlitt, 2018 .

Efficacy and Safety of TiNO-Coated Stents versus Drug-Eluting Stents in Acute Coronary Syndrome: Systematic Literature Review and Meta-Analysis

P. Coste, P. Karjalainen, F. Daoud, 2022, Biomedicines.

One‐Year Outcome of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: An Analysis of the AFCAS Registry

P. Kirchhof, M. Niemelä, S. Vikman, 2014, Clinical cardiology.

Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting.

M. Niemelä, S. Vikman, T. Vahlberg, 2007, European heart journal.

Renal sympathetic denervation for treatment of patients with atrial fibrillation: Reappraisal of the available evidence.

J. Airaksinen, W. Nammas, P. Karjalainen, 2016, Heart rhythm.

Drug-eluting stents in patients on long-term oral anticoagulation therapy: a mission impossible?

P. Karjalainen, A. Ylitalo, K. Airaksinen, 2010 .

Comparison of 30-day and 5-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients aged≤50 years (the Coronary aRtery diseAse in younG adultS Study).

G. Faggian, T. Mäkikallio, C. Vassanelli, 2014, The American journal of cardiology.

Neointimal Healing Evaluated by Optical Coherence Tomography after Drug-Eluting Absorbable Metal Scaffold Implantation in de novo Native Coronary Lesions: Rationale and Design of the Magmaris-OCT Study

W. Nammas, P. Karjalainen, Jussi Sia, 2017, Cardiology.

Optimal stent design: past, present and future

J. Airaksinen, W. Nammas, P. Karjalainen, 2014 .

The REMEDEE-OCT Study: An Evaluation of the Bioengineered COMBO Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent Compared With a Cobalt-Chromium Everolimus-Eluting Stent in Patients With Acute Coronary Syndromes: Insights From Optical Coherence Tomography Imaging Analysis.

R. D. de Winter, M. Joner, T. Lüscher, 2017, JACC. Cardiovascular interventions.

Excellent very early neointimal coverage of bioactive stents by optical coherence tomography

W. Nammas, P. Karjalainen, 2015, Scandinavian cardiovascular journal : SCJ.

Vascular healing early after titanium-nitride-oxide-coated stent implantation assessed by optical coherence tomography.

W. Nammas, T. Kiviniemi, P. Karjalainen, 2013, The Journal of invasive cardiology.

Epitranscriptomics of Ischemic Heart Disease—The IHD-EPITRAN Study Design and Objectives

M. Karelson, M. Lalowski, S. Katayama, 2021, International journal of molecular sciences.

Gender-based analysis of the 3-year outcome of bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: an insight from the TITAX-AMI trial.

M. Niemelä, W. Nammas, P. Karjalainen, 2012, The Journal of invasive cardiology.

Titanium and nitride oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population.

J. Airaksinen, P. Karjalainen, A. Ylitalo, 2006, The Journal of invasive cardiology.

Moderated Posters session IV: Viability and recovery of systolic function. The echo approach * Friday 10 December 2010, 15:30-16:30

A. Støylen, L. Vatten, J. D’hooge, 2010 .

Outcome of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with titanium-nitride-oxide-coated versus everolimus-eluting stents: insights from the BASE-ACS trial.

W. Nammas, P. Karjalainen, M. Pietilä, 2013, Minerva cardioangiologica.

Titanium-nitride-oxide-coated coronary stents: insights from the available evidence

W. Nammas, P. Karjalainen, 2017, Annals of medicine.

Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: long-term follow-up from the TITAX AMI trial.

M. Niemelä, W. Nammas, P. Karjalainen, 2013, International journal of cardiology.

Early vascular healing after titanium–nitride–oxide-coated stent versus platinum–chromium everolimus-eluting stent implantation in patients with acute coronary syndrome

J. Airaksinen, W. Nammas, T. Kiviniemi, 2016, The International Journal of Cardiovascular Imaging.

Early neointimal coverage and vasodilator response following biodegradable polymer sirolimus-eluting vs. durable polymer zotarolimus-eluting stents in patients with acute coronary syndrome –HATTRICK-OCT trial.

J. Airaksinen, W. Nammas, T. Kiviniemi, 2015, Circulation journal : official journal of the Japanese Circulation Society.

Efficacy and safety of TiNO-coated stents versus drug-eluting coronary stents. Systematic literature review and meta-analysis.

P. Coste, P. Karjalainen, F. Daoud, 2020, medRxiv.

Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention

M. Niemelä, W. Nammas, P. Karjalainen, 2022 .

Bacterial Signatures in Thrombus Aspirates of Patients With Myocardial Infarction

T. Lehtimäki, J. Airaksinen, R. Laaksonen, 2013, Circulation.

Lead-Lag Structure between the R&D Investments and Market Values

P. Karjalainen, 2004 .

How creditor rights affect the value of cash: A cross-country study

P. Karjalainen, Irene Tan, Petri Kyröläinen, 2013 .

Real world experience with the TITAN(R) stent: a 9-month follow-up report from The Titan PORI Registry.

P. Karjalainen, K. J. Juhani Airaksinen, A. Ylitalo, 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole

G. Hindricks, A. Bollmann, Yanchun Liang, 2023, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Optimal stent design : past , present & future perspective

J. Airaksinen, W. Nammas, P. Karjalainen, 2014 .

Feasibility and safety of frequency-domain optical coherence tomography for coronary artery evaluation: a single-center study

J. Airaksinen, W. Nammas, P. Karjalainen, 2013, The International Journal of Cardiovascular Imaging.

Optical coherence tomography follow-up 18 months after titanium-nitride-oxide-coated versus everolimus-eluting stent implantation in patients with acute coronary syndrome

W. Nammas, P. Karjalainen, A. Ylitalo, 2017, Acta radiologica.

Optical coherence tomography: on the way to decipher the 'Rosetta stone'.

W. Nammas, P. Karjalainen, 2012, International journal of cardiology.

Titanium-Nitride-Oxide-Coated Versus Everolimus-Eluting Stents in Acute Coronary Syndrome: The Randomized TIDES-ACS Trial.

J. Airaksinen, W. Nammas, P. Karjalainen, 2020, JACC. Cardiovascular interventions.

A prospective randomised comparison of titanium-nitride-oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: the BASE-ACS trial.

M. Niemelä, O. Hess, J. Airaksinen, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Gender-based analysis of randomized comparison of bioactive versus everolimus-eluting stents in acute coronary syndrome

M. Niemelä, J. Airaksinen, W. Nammas, 2015, Journal of cardiovascular medicine.

Transthoracic echocardiography for non-invasive assessment of coronary vasodilator function after DES implantation.

J. Airaksinen, T. Kiviniemi, P. Karjalainen, 2014, European heart journal cardiovascular Imaging.

Focused echocardiography and lung ultrasound protocol for guiding treatment in acute heart failure

P. Karjalainen, V. Harjola, J. Lassus, 2017, ESC heart failure.

Titanium-nitride-oxide-coated Titan-2 bioactive coronary stent: a new breakthrough in interventional cardiology.

W. Nammas, P. Karjalainen, 2011, Minerva cardioangiologica.

Comparison of two different sampling intervals for optical coherence tomography evaluation of neointimal healing response after coronary stent implantation.

J. Airaksinen, W. Nammas, T. Kiviniemi, 2017, International journal of cardiology.

Five-Year Efficacy and Safety of TiNO-Coated Stents Versus Drug-Eluting Stents in Acute Coronary Syndrome: A Meta-Analysis

P. Karjalainen, B. Catargi, E. Gerbaud, 2023, medRxiv.

Titanium-Nitride-Oxide-Coated vs Everolimus-Eluting Stents in Acute Coronary Syndrome: 5-Year Clinical Outcomes of the TIDES-ACS Randomized Clinical Trial.

J. Airaksinen, F. Bouisset, P. Karjalainen, 2023, JAMA cardiology.

Reply: The Randomized TIDES-ACS Trial.

P. Karjalainen, B. De Bruyne, N. Pijls, 2020, JACC. Cardiovascular interventions.

Usefulness of Post-coronary Dilation to Prevent Recurrent Myocardial Infarction in Patients Treated With Percutaneous Coronary Intervention for Acute Coronary Syndrome (from the BASE ACS Trial).

M. Niemelä, J. Airaksinen, W. Nammas, 2017, The American journal of cardiology.

Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study

P. Karjalainen, A. Ylitalo, K. Airaksinen, 2012, The International Journal of Cardiovascular Imaging.

Titanium-nitride-oxide-coated Titan-2 bioactive coronary stent: a new horizon for coronary intervention

J. Airaksinen, W. Nammas, P. Karjalainen, 2010, Expert review of medical devices.

The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation

P. Kirchhof, M. Niemelä, S. Vikman, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Renal sympathetic denervation for treatment of patients with heart failure: summary of the available evidence.

W. Nammas, P. Karjalainen, J. Koistinen, 2017 .

Outcome of poor initial TIMI flow in patients presenting with acute coronary syndrome

W. Nammas, P. Karjalainen, M. Pietilä, 2017, Scandinavian cardiovascular journal : SCJ.

Long-term safety of drug-eluting stents in patients on warfarin treatment

M. Niemelä, S. Vikman, P. Karjalainen, 2012, Annals of medicine.

Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment.

M. Niemelä, S. Vikman, T. Vahlberg, 2008, European heart journal.

One‐Year Outcome of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: An Analysis of the AFCAS Registry

P. Kirchhof, M. Niemelä, S. Vikman, 2014, Clinical cardiology.

Bacterial Signatures in Thrombus Aspirates of Patients With Myocardial Infarction

T. Lehtimäki, J. Airaksinen, R. Laaksonen, 2013, Circulation.

Usefulness of Post-coronary Dilation to Prevent Recurrent Myocardial Infarction in Patients Treated With Percutaneous Coronary Intervention for Acute Coronary Syndrome (from the BASE ACS Trial).

M. Niemelä, J. Airaksinen, W. Nammas, 2017, The American journal of cardiology.

Bacterial Signatures in Thrombus Aspirates of Patients with Myocardial Infarction Running Title: Pessi Et Al.; Oral Bacteria and Myocardial Infarction

J. Airaksinen, R. Laaksonen, P. Karjalainen, 2022 .